Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Melanoma 3Leukemia 3Congenital Abnormalities 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Graft vs Host Disease 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Blast Crisis 2Uveal Melanoma 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1

Interventions

Paclitaxel 6Taxes 5Carboplatin 5Immunoglobulin G 2Disulfides 2Bevacizumab 2sargramostim 1liposomal doxorubicin 1emactuzumab 1elesclomol 1belinostat 1adavosertib 1VTX-2337 1Surgical Procedures, Operative 1Metformin 1Immunologic Techniques 1Imatinib Mesylate 1Granulocyte-Macrophage Colony-Stimulating Factor 1Gemcitabine 1Erlotinib Hydrochloride 1Drug Therapy 1Cytoreduction Surgical Procedures 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Brenner Tumor × Immunologic Techniques × Clear all
NCT00466960 2017-08-28

Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous Chemotherapy

University of Washington

Phase 2 Completed
21 enrolled 12 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Brenner Tumor, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡